Literature DB >> 22392620

Simultaneous screening of glutathione and cyanide adducts using precursor ion and neutral loss scans-dependent product ion spectral acquisition and data mining tools.

Wenying Jian1, Hua-Fen Liu, Weiping Zhao, Elliott Jones, Mingshe Zhu.   

Abstract

Drugs can be metabolically activated to soft and hard electrophiles, which are readily trapped by glutathione (GSH) and cyanide (CN), respectively. These adducts are often detected and structurally characterized using separate tandem mass spectrometry methods. We describe a new method for simultaneous screening of GSH and CN adducts using precursor ion (PI) and neutral loss (NL) scans-dependent product ion spectral acquisition and data mining tools on an triple quadrupole linear ion trap mass spectrometry. GSH, potassium cyanide, and their stable isotope labeled analogues were incubated with liver microsomes and a test compound. Negative PI scan of m/z 272 for detection of GSH adducts and positive NL scans of 27 and 29 Da for detection of CN adducts were conducted as survey scans to trigger acquisition of enhanced resolution (ER) spectrum and subsequent enhanced product ion (EPI) spectrum. Post-acquisition data mining of EPI data set using NL filters of 129 and 27 Da was then performed to reveal the GSH adducts and CN adducts, respectively. Isotope patterns and EPI spectra of the detected adducts were utilized for identification of their molecular weights and structures. The effectiveness of this method was evaluated by analyzing reactive metabolites of nefazodone formed from rat liver microsomes. In addition to known GSH- and CN-trapped reactive metabolites, several new CN adducts of nefazodone were identified. The results suggested that current approach is highly effective in the analysis of both soft and hard reactive metabolites and can be used as a high-throughput method in drug discovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392620     DOI: 10.1007/s13361-012-0354-6

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  42 in total

1.  Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development.

Authors:  Richard A Thompson; Emre M Isin; Yan Li; Richard Weaver; Lars Weidolf; Ian Wilson; Alf Claesson; Ken Page; Hugues Dolgos; J Gerry Kenna
Journal:  Chem Biol Interact       Date:  2010-11-11       Impact factor: 5.192

Review 2.  Analytical strategies for the screening and evaluation of chemically reactive drug metabolites.

Authors:  Bo Wen; William L Fitch
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-01       Impact factor: 4.481

3.  A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide.

Authors:  Kazuko Inoue; Yoshihiro Shibata; Hiroyuki Takahashi; Tomoyuki Ohe; Masato Chiba; Yasuyuki Ishii
Journal:  Drug Metab Pharmacokinet       Date:  2009       Impact factor: 3.614

4.  Peptide-based in vitro assay for the detection of reactive metabolites.

Authors:  Michael D Mitchell; Mollisa M Elrick; Jennie L Walgren; Richard A Mueller; Dale L Morris; David C Thompson
Journal:  Chem Res Toxicol       Date:  2008-03-28       Impact factor: 3.739

Review 5.  Drug metabolite profiling and identification by high-resolution mass spectrometry.

Authors:  Mingshe Zhu; Haiying Zhang; W Griffith Humphreys
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

6.  In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites.

Authors:  Zhoupeng Zhang; Qing Chen; Ying Li; George A Doss; Brian J Dean; Jason S Ngui; Maria Silva Elipe; Seongkon Kim; Jane Y Wu; Frank Dininno; Milton L Hammond; Ralph A Stearns; David C Evans; Thomas A Baillie; Wei Tang
Journal:  Chem Res Toxicol       Date:  2005-04       Impact factor: 3.739

Review 7.  Novel MS solutions inspired by MIST.

Authors:  Ragu Ramanathan; Jonathan L Josephs; Mohammed Jemal; Mark Arnold; W Griffith Humphreys
Journal:  Bioanalysis       Date:  2010-07       Impact factor: 2.681

8.  Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature.

Authors:  Zhengyin Yan; Gary W Caldwell
Journal:  Anal Chem       Date:  2004-12-01       Impact factor: 6.986

9.  Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Authors:  Dayana Argoti; Li Liang; Abdul Conteh; Liangfu Chen; Dave Bershas; Chung-Ping Yu; Paul Vouros; Eric Yang
Journal:  Chem Res Toxicol       Date:  2005-10       Impact factor: 3.739

10.  Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.

Authors:  Jonathan N Bauman; Kosea S Frederick; Aarti Sawant; Robert L Walsky; Loretta M Cox; Ronald S Obach; Amit S Kalgutkar
Journal:  Drug Metab Dispos       Date:  2008-03-10       Impact factor: 3.922

View more
  4 in total

1.  The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins.

Authors:  Michele Scian; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2015-08-14       Impact factor: 4.013

2.  A generic multiple reaction monitoring based approach for plant flavonoids profiling using a triple quadrupole linear ion trap mass spectrometry.

Authors:  Zhixiang Yan; Ge Lin; Yang Ye; Yitao Wang; Ru Yan
Journal:  J Am Soc Mass Spectrom       Date:  2014-04-02       Impact factor: 3.109

3.  The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors.

Authors:  Na Le Dang; Matthew K Matlock; Tyler B Hughes; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-02-24       Impact factor: 4.956

4.  In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics.

Authors:  Sin-Eun Kim; Hyung-Ju Seo; Yeojin Jeong; Gyung-Min Lee; Seung-Bae Ji; So-Young Park; Zhexue Wu; Sangkyu Lee; Sunghwan Kim; Kwang-Hyeon Liu
Journal:  Pharmaceutics       Date:  2021-06-23       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.